Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the anthelmintic drugs market grown in recent years?

The anthelmintic drugs market has seen strong growth, projected to grow from $3.16 billion in 2024 to $3.34 billion in 2025, at a CAGR of 5.6%. Past growth has been attributed to the high prevalence of helminth infections, public health initiatives, advancements in pharmaceutical research and development, increasing awareness and education, and economic expansion.

How is the anthelmintic drugs market size expected to evolve during the forecast period?

The anthelmintic drugs market is projected to experience substantial growth, reaching $4.11 billion by 2029 with a CAGR of 5.3%. Growth drivers include rising cases of parasitic infections, increased use in livestock and pets, heightened health awareness initiatives, and increased global travel. Key trends include a growing preference for combination therapies, efforts to manage drug resistance, wider adoption of personalized medicine, telemedicine expansion in treatment monitoring, advancements in novel drug targets, and a focus on preventive healthcare.

Get your anthelmintic drugs market report here!

https://www.thebusinessresearchcompany.com/report/anthelmintic-drugs-global-market-report

Which key drivers are propelling the anthelmintic drugs market’s growth?

The increasing prevalence of parasitic infections is expected to drive the anthelmintic drugs market. These infections, caused by parasites like protozoa, worms, or ectoparasites, are linked to poor sanitation, contaminated food or water, close contact with infected hosts, and inadequate hygiene. Anthelmintic drugs help eliminate these parasites by disrupting their physiological functions. For instance, in July 2023, data from the Centers for Disease Control and Prevention showed that cyclosporiasis cases in Florida surged from 254 in 2021 to 513 in 2022. This rising prevalence of parasitic infections is fueling the market’s growth.

What are the market segments in the anthelmintic drugs industry?

The anthelmintic drugsmarket covered in this report is segmented –

1) By Drug Class: Benzimidazoles, Macrocyclic lactones, Pyrazinoisoquinolones, Tetrahydropyrimidines, Other Drug Classes

2) By Route Of Administration: Oral, Injectable

3) By Infection Type: Nematode Infections, Cestode Infections, Trematode Infections, Mixed Infections

4) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Clinics And Supply Stores

5) By Application: Human Anthelmintics, Veterinary Anthelmintics

Subsegments:

1) By Benzimidazoles: Albendazole, Mebendazole, Fenbendazole, Oxfendazole, Thiabendazole

2) By Macrocyclic Lactones: Ivermectin, Moxidectin, Doramectin, Eprinomectin, Milbemycin Oxime

3) By Pyrazinoisoquinolones: Praziquantel, Cysticide

4) By Tetrahydropyrimidines: Pyrantel Pamoate, Pyrantel Tartrate

5) By Other Drug Classes: Imidazothiazoles, Aminoacetonitrile Derivatives, Spiroindoles, Arsenicals

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19291&type=smp

Which leading companies are shaping the growth of the anthelmintic drugs market?

Major companies operating in the anthelmintic drugs market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Zoetis Inc., Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Galderma S.A., Cipla Inc., Ferring Pharmaceuticals Inc., Amneal Pharmaceuticals, Inc., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Mankind Pharma Ltd., Reese Pharmaceutical Company

What key trends are currently impacting the anthelmintic drugs market’s development?

Leading companies in the anthelmintic drugs market are prioritizing the development of combination drugs to offer comprehensive protection against multiple parasites. These formulations integrate two or more anthelmintic agents to enhance efficacy, expand the spectrum of activity, and combat drug resistance in both humans and animals. In January 2022, Zoetis Inc., a US-based animal health company, received FDA approval for Simparica Trio, a new label indication to prevent infections caused by Borrelia burgdorferi, the bacteria responsible for Lyme disease in dogs. Simparica Trio includes sarolaner, moxidectin, and pyrantel, providing broad-spectrum protection against fleas, ticks, heartworms, roundworms, and hookworms.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19291

Which geographic areas are influencing the growth of the anthelmintic drugs market?

North America was the largest region in the anthelmintic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthelmintic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Fertility Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Ovarian Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ovarian-cancer-drugs-global-market-report

Kidney Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/kidney-cancer-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: